#biotechnology (2 Posts)
-
New Brain Cancer Drug Taps Into the Body's Internal Clock SHP1705 shows promise in inhibiting glioblastoma stem cells by targeting circadian clock proteins, enhancing cancer treatment efficacy. -
AstraZeneca Bets Big on Cell Therapy with $1B ISOBiotech Acquisition AstraZeneca will acquire ISOBiotech for $1 billion, enhancing its cell therapy capabilities and reducing treatment times significantly.
Hot Topics